Skip to main content

Breadcrumb

  1. Home

Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

MARGetuximab Or Trastuzumab (MARGOT)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about MARGetuximab Or Trastuzumab (MARGOT)

Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC

A Study of SHR-A1811 in Subjects With Advanced Malignant Solid Tumors

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study of SHR-A1811 in Subjects With Advanced Malignant Solid Tumors

Study of CG0070 Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Study of CG0070 Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

The Tether™ - Vertebral Body Tethering System Post Approval Study

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about The Tether™ - Vertebral Body Tethering System Post Approval Study

A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer

A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 204
  • Page 205
  • Page 206
  • Page 207
  • Page 208
  • Page 209
  • Page 210
  • Page 211
  • Page 212
  • …
  • Next page Next
  • Last page Last
Subscribe to